Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2003
09/18/2003US20030176416 For therapy of disease, disorder or condition is responsive to modulation of cholinergic receptors and/or monoamine receptors
09/18/2003US20030176408 For topical application, penetration
09/18/2003US20030176405 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens
09/18/2003US20030176383 Antisense modulation of p38 mitogen activated protein kinase expression
09/18/2003US20030176379 Useful in the administration of a drug, therapy
09/18/2003US20030176366 Topical application of ascorbic acid compounds for augmenting the synthesis of epidermal ceramides
09/18/2003US20030176363 For therapy of T lymphocyte mediated inflammatory diseases in animals and man
09/18/2003US20030176318 Administering a therapeutically effective amount of a temporary p53 inhibitor to an individual suffering from the disease or condition
09/18/2003US20030176315 Contacting latency-associated peptide- beta 1 (LAP- beta 1) or a functional variant thereof and integrin alpha v beta 3 or a functional variant thereof with test product under conditions that, in absence of test product, would permit interaction
09/18/2003US20030175934 Controlling cell differentiation, cell proliferation; anticancer agents
09/18/2003US20030175895 Chemokine
09/18/2003US20030175881 Nucleic acids encoding (poly) peptides having chips activity
09/18/2003US20030175840 Kit which detects ligand associated with nuclear factor kappa beta receptor for treating toxic shock, sepsis, inflammation and graft vs host disease
09/18/2003US20030175775 Ligand for G-protein coupled receptor GPR43 and uses thereof
09/18/2003US20030175711 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays
09/18/2003US20030175374 Oxidation resistance; anticancer agents, antiinflammatory agents; sunscreen agents
09/18/2003US20030175370 Dry mixture of carbohydrates and drugs; wound healing agents
09/18/2003US20030175334 Phospholipid bodies and use thereof in medical treatment
09/18/2003US20030175331 Pressure sensitive adhesive comprising isoprene-styrene block copolymer/tackifier resin and diclofenac sodium
09/18/2003US20030175290 Molecular antigen array
09/18/2003US20030175289 TIE ligands
09/18/2003US20030175280 Antagonists to chaperonin 10
09/18/2003US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents
09/18/2003US20030175269 Light and heavy chain peptides, used as antagonists of CD antigen or membrane proteins, for prophylaxis of autoimmune diseases
09/18/2003US20030175267 Method for the treatment of inflammatory joint disease
09/18/2003US20030175238 Chemokine conjugates
09/18/2003US20030175205 Comprising a radioactive materials for detecting and/or quantifying diseases or conditions associated with cancer, infections, inflammation; a 2-propane carboxylic ester with a attached phosphatidic acid group
09/18/2003CA2482191A1 Spiro compounds with npy antagonistic activity
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003CA2478958A1 Use of proton pump inhibitors for the treatment of airway disorders
09/18/2003CA2478942A1 An optically active pyridine derivative and a medicament containing the same
09/18/2003CA2478936A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003CA2478921A1 Novel chalcone derivatives and uses thereof
09/18/2003CA2478897A1 Compounds capable of inhibiting immunocyte-related allergic immune reactions
09/18/2003CA2478706A1 Oxo-azabicyclic compounds
09/18/2003CA2478701A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003CA2478684A1 Dispersed solid-containing complex carbohydrate
09/18/2003CA2478522A1 Novel curcuminoid-factor viia constructs as suppressors of tumor growth and angiogenesis
09/18/2003CA2478317A1 Methods of preventing or treating disorders by administering an integrin .alpha.v.beta.3 antagonist in combination with an hmg-coa reductase inhibitor or a bisphosphonate
09/18/2003CA2478245A1 Treatment and prevention of inflammatory disorders
09/18/2003CA2478065A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003CA2477949A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
09/18/2003CA2477393A1 Ibuprofen solution for hard shell capsules
09/18/2003CA2476031A1 Novel substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
09/18/2003CA2474771A1 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
09/17/2003EP1344823A1 Novel g protein-coupled receptor proteins and dnas thereof
09/17/2003EP1344779A1 Azolo-pyrimidines
09/17/2003EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
09/17/2003EP1344523A1 Ibuprofen solution for hard gelatin capsules
09/17/2003EP1343876A2 Modulators of activity of g-protein-coupled receptor kinases
09/17/2003EP1343818A1 Modified tachykinin receptors
09/17/2003EP1343803A2 2-substituted estrogens as antiangiogenic agents
09/17/2003EP1343789A1 Tricyclic derivatives of indole with antiangiogenic activity
09/17/2003EP1343786A1 Novel pyridine-substituted pyrazolopyridine derivatives
09/17/2003EP1343784A2 Urea substituted imidazoquinoline ethers
09/17/2003EP1343781A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
09/17/2003EP1343778A2 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
09/17/2003EP1343774A1 1,1-dioxo-2h-1, 2-benzothiazine-3-carboxamide derivatives, method for preparing same and pharmaceutical compositions comprising same
09/17/2003EP1343769A1 Benzoylpyridazines
09/17/2003EP1343764A1 Urea and urethane derivatives as integrin inhibitors
09/17/2003EP1343763A1 Pyrodone derivatives as ap2 inhibitors
09/17/2003EP1343759A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands
09/17/2003EP1343757A1 Indole derivatives
09/17/2003EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity
09/17/2003EP1343561A1 Serine protease inhibitors
09/17/2003EP1343529A2 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
09/17/2003EP1343520A2 New therapeutic uses of smr1 peptides
09/17/2003EP1343519A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders
09/17/2003EP1343513A1 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use
09/17/2003EP1343512A1 Injectable solution with anti-inflammatory effect and process for manufacturing the same
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1343492A2 Treatment of mucositis
09/17/2003EP1343488A1 Treatment of statin side effects
09/17/2003EP1343487A2 Methods and compositions to treat conditions associated with neovascularization
09/17/2003EP1343479A2 Aerogel powder therapeutic agents
09/17/2003EP1314426A9 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
09/17/2003EP1282622B1 Crf receptor antagonists and methods relating thereto
09/17/2003EP1196411B1 Bradykinin b1 receptor antagonists
09/17/2003EP1183241B1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
09/17/2003EP1169056B1 Caspase-8 inhibitors for immunosuppression.
09/17/2003EP1147119B1 2,3-o-isoproylidene derivatives of monosaccharides as cell adhesion inhibitors
09/17/2003EP1133471B1 Hydrazine derivatives
09/17/2003EP1100471B1 Compressed compositions comprising clarified xanthan gum
09/17/2003EP1095021B1 Quinoline derivatives
09/17/2003EP0996446B1 Novel substituted imidazole compounds
09/17/2003EP0891329B1 Peptidyl compounds having mmp and tnf inhibitory activity
09/17/2003EP0769940B1 INDENE sPLA2 INHIBITORS
09/17/2003EP0724647A4 Nucleic acid ligands and improved methods for producing the same
09/17/2003EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
09/17/2003CN1443199A Antibodies to human MCP-1
09/17/2003CN1443190A Matrix metalloproteinase inhibitors
09/17/2003CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function
09/17/2003CN1443173A Substituted imidazoles as TAFI a inhibitors
09/17/2003CN1443170A Capsaicin receptor ligands
09/17/2003CN1443168A 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis
09/17/2003CN1443166A 4-benzyl-1-[2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3, 4-diol
09/17/2003CN1443160A N-substituted-1-amino-1,1-dialkyl carboxylic acid derivatives
09/17/2003CN1443158A Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products
09/17/2003CN1443073A Process for preparing composition comprising medicinal herb extract for preventing and curing arthritis and composition thereof
09/17/2003CN1443070A Apoptosis inhibiting composition comprising 15-keto-prostaglandin or derivative thereof
1 ... 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 ... 1272